stockrow
Friday 6 November 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024.
- Revenue
- +7.02%
- EPS
- +24.2%
- Free cash flow
- −17.1%
- Total debt
- −85.4%
Quarter to September 2026, against a year earlier
124.38
2.43
−1.92%
Follow ADUS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
18.42 | 17.63 | 17.31 | 20.61 |
+8 more quarters Free account |
P/S ratio |
1.35 | 1.24 | 1.18 | 1.36 | |
P/FCF ratio |
14.02 | 11.88 | 12.41 | 18.70 | |
P/Operating CF |
49.42 | 45.93 | 32.54 | 103.33 | |
P/B ratio |
1.76 | 1.60 | 1.53 | 1.79 | |
Price to Tangible BV |
47.42 | 45.15 | 89.72 | 0.00 | |
EV/Sales |
1.30 | 1.22 | 1.17 | 1.39 | |
EV/EBITDA |
11.26 | 10.83 | 10.58 | 12.66 | |
EV/Operating CF |
12.80 | 11.09 | 11.68 | 17.75 | |
EV/FCF |
13.49 | 11.64 | 12.33 | 19.09 | |
Quick Ratio |
1.51 | 1.46 | 1.66 | 1.56 | |
Current Ratio |
1.64 | 1.69 | 1.83 | 1.80 | |
Net Debt/EBITDA |
0.00 | (0.87) | (0.31) | 0.84 | |
Debt/Assets |
1.51% | 4.23% | 6.36% | 8.42% | |
Debt/Equity |
0.02 | 0.05 | 0.08 | 0.11 | |
Asset Turnover |
1.05 | 1.03 | 1.02 | 1.00 | |
Operating CF/Net income |
1.43 | 1.45 | 2.09 | 0.63 | |
Capex/Depreciation |
(0.45) | (0.30) | (0.39) | (0.59) | |
Interest Coverage |
58.73 | 22.59 | 15.84 | 15.51 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.75% | 20.80% | 21.39% | 20.69% | |
Intangible Assets out of Total Assets |
0.76 | 0.76 | 0.76 | 0.76 | |
Share Based Compensation of Revenue |
0.00% | 1.16% | 1.38% | 1.22% | |
Graham Net Nets |
0.01 | (0.01) | (0.03) | (0.04) | |
Graham Number |
0.00 | 89.72 | 86.42 | 83.95 | |
Earnings Yield |
5.43% | 5.67% | 5.78% | 4.85% | |
Free Cash Flow Yield |
7.13% | 8.42% | 8.06% | 5.35% | |
Revenue per Share |
0.00 | 20.63 | 19.99 | 20.67 | |
Operating CF per Share |
0.00 | 2.19 | 2.88 | 1.04 | |
Capex per Share |
(0.11) | (0.07) | (0.09) | (0.15) | |
Free Cash Flow per Share |
0.00 | 2.12 | 2.79 | 0.89 | |
Cash per Share |
0.00 | 5.44 | 5.66 | 4.52 | |
Shareholders Equity per Share |
0.00 | 62.77 | 61.35 | 60.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 62.77 | 61.35 | 60.12 | |
Free Cash Flow |
40.91 | 38.69 | 50.67 | 16.11 | |
Working Capital |
109.78 | 116.00 | 123.40 | 120.00 | |
Capital Expenditures |
(1.99) | (1.32) | (1.69) | (2.66) | |
Net Current Asset Value |
10.80 | (24.18) | (46.66) | (82.51) | |
EV/EBIT |
12.55 | 12.15 | 11.91 | 14.28 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Price to Operating Income |
13.04 | 12.40 | 11.98 | 13.99 | |
| Other line items | |||||
Average Receivables |
147.46 | 142.61 | 139.72 | 137.29 | |
Average Payables |
18.40 | 16.86 | 21.00 | 22.00 | |
Average Assets |
1,436.56 | 1,432.71 | 1,421.64 | 1,424.97 | |
Average Common Equity |
1,114.87 | 1,085.01 | 1,055.77 | 1,027.90 |
Columns are period end dates · fundamentals updated 5 Nov 2026